TODAY’S TRADEMARK – CHILDREN’S BENADRYL

The trademark CHILDREN’S BENADRYL, owned by KENVUE INC., was registered in USPTO bearing registration number 4735675 on May 12, 2015.

“Children’s Benadryl by Kenvue” is a trusted brand of allergy medication designed specifically for children, offering relief from symptoms such as sneezing, itching, watery eyes, and runny nose caused by allergies or the common cold. Produced by Kenvue Pharmaceuticals, this formulation is tailored to meet the unique needs of pediatric patients, providing safe and effective relief for children experiencing allergy-related discomfort.

The active ingredient in Children’s Benadryl is diphenhydramine, a first-generation antihistamine known for its ability to alleviate allergy symptoms by blocking the action of histamine, a chemical released by the body during allergic reactions. Available in various forms such as liquid, chewable tablets, and dissolvable strips, Children’s Benadryl by Kenvue offers convenient dosing options suitable for children of different ages and preferences.

Kenvue Pharmaceuticals is committed to ensuring the safety and efficacy of its products, including Children’s Benadryl, through rigorous quality control measures and adherence to regulatory standards.